FDA faces conundrum over future of AMAG’s Makena following drug withdrawal
GlobalData believes that either an FDA decision to remove the drug from the market or a request for a new...
Trending menu:
-
![Majority of Alzheimer’s disease clinical trials in the US parked in Phase I]()
Majority of Alzheimer’s disease clinical trials in the US parked in Phase I
-
![Poseidon reaps success for AstraZeneca’s Imfinzi in non-small cell lung cancer]()
Poseidon reaps success for AstraZeneca’s Imfinzi in non-small cell lung cancer
-
![AstraZeneca’s Flaura lung cancer results favour further first-line Tagrisso use]()
AstraZeneca’s Flaura lung cancer results favour further first-line Tagrisso use
-
![Ayala plans Phase II cancer studies to start by first half of 2020]()
Ayala plans Phase II cancer studies to start by first half of 2020
-
![Benchmarking Phase II industry-sponsored pancreatic cancer trials]()
Benchmarking Phase II industry-sponsored pancreatic cancer trials
-
![Janssen seeks expansion into psoriatic arthritis with latest Tremfya FDA filing]()
Janssen seeks expansion into psoriatic arthritis with latest Tremfya FDA filing
Expert commentary & analysis from GlobalData
2018 was a top year for clinical trials for depression
Top industry sponsors of checkpoint modulator trials
Celldex stops Phase Ib/II trial in melanoma due to GI toxicities after enrolling three patients
Amgen’s AMG510 combo exploration in colorectal cancer tumours poised for late 2019, early 2020
Most Read
Company releases
Malvern’s Forthcoming Events
Here are the forthcoming shows that will exhibit Malvern’s clinical solutions.
ACTide to Attend CPhI Worldwide 2019
Manufacturers Choose the Mastersizer 3000 for Accuracy and Efficiency
In 2016, Metals and Additives LLC, a leading manufacturer and supplier of powder additives for the battery and plastics industries,...
AtreMorine for Parkinson’s Disease and Dopamine-Related Disorders
3DforScience to Exhibit at the Partnering Convention, 11-13 November
BIO Europe Partnering is a premier bioscience conference, which brings nearly 5,000 delegates from a...
Company whitepapers
Supporting the Pharmaceutical Industry, 21 CFR Part 11 Compliance Readiness
Malvern PanalyticalIKA Laboratory Equipment Brochure
Ika-WerkePrimary Cells Isolated from Healthy Human and Animal Tissues
Caltag MedsystemsImprove Endpoint Adjudication Efficiency with Ethical™ Adjudication®
EthicalIKA Case Study: Sustainable Processes for Textile Surfaces
Ika-WerkeSTZ-Induced Rat Model of Diabetes
Noble Life SciencesVisuals for Bio&Health
3DforScienceCompany A-Z
Clinical Trials
ClinOne and Boston Children’s Hospital partner for trial enhancement
ClinOne has launched its eConsent with Video eConsent technology in collaboration with Boston Children’s Hospital (BCH).
Alnylam begins Phase III trial of lumasiran in PH1
Genentech’s Gazyva improves renal response in lupus nephritis patients
Daiichi Sankyo’s Phase III trial of esaxerenone meets primary goal
TrialAssure launches document anonymisation tool using AI
Drug Development
Takeda’s dengue vaccine shows promise in Phase III trial
Takeda Pharmaceutical has reported positive results from the ongoing Phase III TIDES clinical trial of its dengue vaccine candidate, TAK-003.
Catalyst’s Phase III trial of Firdapse in CMS fails to meet goals
Zogenix’s Fintepla reduces seizures in study participants
Tecentriq and Avastin improves survival in Phase III cancer trial
FDA accepts BLA from AstraZeneca and Daiichi for targeted chemotherapy
Go Top